HK1003418A1 - The combination of growth hormone and insulin-like growth factor, for treating congestive heart failure - Google Patents

The combination of growth hormone and insulin-like growth factor, for treating congestive heart failure

Info

Publication number
HK1003418A1
HK1003418A1 HK98102461A HK98102461A HK1003418A1 HK 1003418 A1 HK1003418 A1 HK 1003418A1 HK 98102461 A HK98102461 A HK 98102461A HK 98102461 A HK98102461 A HK 98102461A HK 1003418 A1 HK1003418 A1 HK 1003418A1
Authority
HK
Hong Kong
Prior art keywords
combination
heart failure
mammal
congestive heart
insulin
Prior art date
Application number
HK98102461A
Other languages
English (en)
Inventor
Ross G Clark
Hongkui Jin
Nicholas F Paoni
Renhui Yang
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/284,859 external-priority patent/US5661122A/en
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of HK1003418A1 publication Critical patent/HK1003418A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/30—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
HK98102461A 1994-04-15 1998-03-24 The combination of growth hormone and insulin-like growth factor, for treating congestive heart failure HK1003418A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US22792394A 1994-04-15 1994-04-15
US08/284,859 US5661122A (en) 1994-04-15 1994-08-02 Treatment of congestive heart failure
US08/333,909 US5610134A (en) 1994-04-15 1994-11-03 Treatment of congestive heart failure
PCT/US1995/003755 WO1995028174A1 (en) 1994-04-15 1995-03-30 The combination of growth hormone and insulin-like growth factor, for treating congestive heart failure

Publications (1)

Publication Number Publication Date
HK1003418A1 true HK1003418A1 (en) 1998-10-30

Family

ID=27397790

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98102461A HK1003418A1 (en) 1994-04-15 1998-03-24 The combination of growth hormone and insulin-like growth factor, for treating congestive heart failure

Country Status (13)

Country Link
US (1) US5610134A (xx)
EP (1) EP0755265B1 (xx)
JP (1) JP3473623B2 (xx)
AT (1) ATE208209T1 (xx)
AU (1) AU691273B2 (xx)
CA (1) CA2185998C (xx)
DE (1) DE69523747T2 (xx)
DK (1) DK0755265T3 (xx)
ES (1) ES2167427T3 (xx)
HK (1) HK1003418A1 (xx)
LV (1) LV12966B (xx)
PT (1) PT755265E (xx)
WO (1) WO1995028174A1 (xx)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3182307B2 (ja) * 1994-12-27 2001-07-03 株式会社荏原製作所 全周流型ポンプ
US5741776A (en) * 1995-05-22 1998-04-21 Genentech, Inc. Method of administration of IGF-I
TW432073B (en) 1995-12-28 2001-05-01 Pfizer Pyrazolopyridine compounds
AU2334097A (en) * 1996-03-21 1997-10-10 Merck & Co., Inc. 4-spiroindoline piperidines promote release of growth hormone
US6306826B1 (en) 1997-06-04 2001-10-23 The Regents Of The University Of California Treatment of heart failure with growth hormone
US6015384A (en) * 1998-08-31 2000-01-18 Acuson Corporation Ultrasonic system and method for tissue viability imaging
SE9901634D0 (sv) * 1999-05-05 1999-05-05 Sahltech Ab Treatment of myocardial infarction with a substance related to the growth hormone axis
JP2003504343A (ja) * 1999-07-12 2003-02-04 ジェネンテック・インコーポレーテッド 腫瘍壊死因子リガンド／レセプター相同体による血管形成及び心血管形成の促進と抑制
CA2378949C (en) * 1999-07-12 2015-03-31 Grandis Biotech Gmbh Growth hormone formulations
WO2001059100A2 (en) * 2000-02-11 2001-08-16 Genentech, Inc. Inhibitor of hepatocyte growth factor activator for use in modulation of angiogenesis and cardiovascularization
FR2805051B1 (fr) * 2000-02-14 2002-12-06 Geophysique Cie Gle Methode de surveillance sismique d'une zone souterraine par utilisation simultanee de plusieurs sources vibrosismiques
EP2792747A1 (en) 2000-06-23 2014-10-22 Genentech, Inc. Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
CA2648051A1 (en) 2000-06-23 2002-01-03 Genentech, Inc. Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
US7547674B2 (en) 2001-06-06 2009-06-16 New York Medical College Methods and compositions for the repair and/or regeneration of damaged myocardium
US7862810B2 (en) 2000-07-31 2011-01-04 New York Medical College Methods and compositions for the repair and/or regeneration of damaged myocardium
WO2002009650A2 (en) 2000-07-31 2002-02-07 New York Medical College Methods and compositions for the repair and/or regeneration of damaged myocardium
US20030224984A1 (en) * 2001-06-20 2003-12-04 Genentech, Inc. Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
US6607517B1 (en) 2001-08-24 2003-08-19 Radiant Medical, Inc. Method of inotropic treatment of heart disease using hypothermia
KR20050090430A (ko) 2002-12-31 2005-09-13 알투스 파마슈티컬스 인코포레이티드 인간 성장 호르몬 결정 및 이것의 제조 방법
US20080103457A1 (en) * 2005-01-11 2008-05-01 Heart Failure Technologies, Inc. University Enterprise Laboratories (Uel) Method and System for Treating Heart Failure
AU2008323719B2 (en) 2007-11-09 2013-04-04 New York Medical College Methods for the repair and/or regeneration of damaged myocardium using variants of hepatocyte growth factor
AU2008334058B2 (en) 2007-11-30 2014-07-10 New York Medical College Compositions comprising vascular and myocyte progenitor cells and methods of their use
US8512696B2 (en) 2007-11-30 2013-08-20 Autologous, Llc Methods of isolating non-senescent cardiac stem cells and uses thereof
EP2225362A1 (en) 2007-11-30 2010-09-08 New York Medical College Methods of reducing transplant rejection and cardiac allograft vasculopathy by implanting autologous stem cells

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5126324A (en) * 1990-06-07 1992-06-30 Genentech, Inc. Method of enhancing growth in patients using combination therapy
WO1992007578A1 (en) * 1990-10-25 1992-05-14 Genentech, Inc. Use of protective agents against reactive oxygen species
SE9100099D0 (sv) * 1991-01-11 1991-01-11 Kabi Pharmacia Ab Use of growth factor
SE9101840L (sv) * 1991-06-14 1992-12-15 Kabi Pharmacia Ny medicinsk anvaendning
WO1993000109A1 (en) * 1991-06-28 1993-01-07 Genentech, Inc. Method of stimulating immune response using growth hormone
US5202119A (en) * 1991-06-28 1993-04-13 Genentech, Inc. Method of stimulating immune response

Also Published As

Publication number Publication date
EP0755265B1 (en) 2001-11-07
JP3473623B2 (ja) 2003-12-08
ES2167427T3 (es) 2002-05-16
US5610134A (en) 1997-03-11
AU2195695A (en) 1995-11-10
DE69523747D1 (de) 2001-12-13
LV12966B (en) 2003-05-20
PT755265E (pt) 2002-04-29
DK0755265T3 (da) 2002-03-04
CA2185998C (en) 2011-02-22
CA2185998A1 (en) 1995-10-26
DE69523747T2 (de) 2002-08-01
EP0755265A1 (en) 1997-01-29
AU691273B2 (en) 1998-05-14
WO1995028174A1 (en) 1995-10-26
ATE208209T1 (de) 2001-11-15
JPH09512008A (ja) 1997-12-02

Similar Documents

Publication Publication Date Title
HK1003418A1 (en) The combination of growth hormone and insulin-like growth factor, for treating congestive heart failure
EP0906119A4 (en) TREATMENT PROCEDURE
MY133569A (en) Method of reducing tissue damage associated with non-cardiac ischemia using glycogen phosphorylase inhibitors
PL338705A1 (en) Application of gaba analogues in preventing and treating gastrointestinal diseases
ES8600062A1 (es) Un metodo para inhibir la mineralizacion de un tejido natural
HK1038307A1 (en) Thymosin beta 4 promotes wound repair.
ES8506455A1 (es) Un metodo de inhibicion de la mineralizacion del tejido natural
GR3021713T3 (en) The combination of growth hormone and insulin-like growth factor-i enhances growth
DK0670729T3 (da) Anvendelse af insulin-lignende vækstfaktorer og analoger til behandling af retinale nervesygdomme
CA2286655A1 (en) Tissue decellularization
GR3036901T3 (en) Treatment of partial growth hormone insensitivity syndrome
GR3033667T3 (en) Use of non-steroidal cyclooxygenase inhibitors to treat elevated intraocular pressure
WO2003020202A3 (en) Method for reducing hypertension and heart failure
CA2088254A1 (en) Treatment for hypercholesterolemia
ES2017808A6 (es) Un metodo para prepara una composicion para inhibir el crecimiento indeseado o patologico de celulas o tejidos.
WO1994000555A3 (en) Compositions for the inhibition of protein hormone formation and uses thereof
CA2032859A1 (en) Method of reducing or preventing adverse effect of steroid therapy and compositions therefor
MX9604803A (es) Combinacion de hormona del crecimiento y factor de crecimiento similar a insulina para el tratamiento del fallo cardiaco congestivo.
ES2138561A1 (es) Uno de los peptidos vip pacap en el tratamiento del abock endotoxico en mamiferos.
EE9800315A (et) Meetod südamepuudulikkuse käitlemiseks endoteliini antagonistide abil
EP0788799A3 (en) LHRH-Antagonists in the treatment of fertility disorders
NO830041L (no) Fremgangsmaate til behandling av azykli hos sauer eller storfe
EP1056458A4 (en) METHODS FOR TREATING PAIN, INCLUDING CHRONIC AND WOMAN-SPECIFIC PAIN
CA2252560A1 (en) Treatment of partial growth hormone insensitivity syndrome
ATE137407T1 (de) Behandlung von intraocularem druck mit einer synergistischen kombination

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20150329